| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corcept Therapeutics Incorporated (CORT) has 10 insiders with recent SEC Form 4 filings, including 5 buys and 7 sells. CORT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $204.85M | -12,837 | |
| Dir | 1.15M | $91.56M | - | |
| Other | 190.0K | $15.17M | - | |
| Other | 84.0K | $6.71M | -75,000 | |
| Other | 78.6K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2018 | Baker G Leonard Jr | Director | Buy | 35,681 | $12.92 | $461,094.86 | +1.3% | |
| Aug 17, 2018 | Baker G Leonard Jr | Director | Buy | 105,792 | $12.50 | $1,322,877.33 | +1.9% | |
| Aug 15, 2018 | Baker G Leonard Jr | Director | Buy | 179,686 | $12.48 | $2,241,967.36 | +5.3% | |
| Aug 7, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $14.15 | $113,184.80 | -100% | |
| Jul 6, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $15.09 | $120,685.60 | -100% | |
| Jun 7, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $18.23 | $145,825.60 | -100% | |
| May 11, 2018 | Baker G Leonard Jr | Director | Sale+OE | 30,000 | $16.01 | $480,312.00 | -3.7% | |
| May 7, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $17.68 | $141,428.00 | -100% | |
| Apr 6, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $16.22 | $129,784.00 | -100% | |
| Mar 7, 2018 | Fishman Robert S | Chief Medical Officer | Sale+OE | 8,000 | $15.67 | $125,323.20 | -100% |